Heterogeneity and Plasticity of Immune Inflammatory Responses in the Tumor Microenvironment: Their Role in the Antitumor Effect and Tumor Aggressiveness


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

This review considers the role that immune inflammatory responses (IIRs) play in tumor development and progression. Intratumoral IIR heterogeneity is presumably due to simultaneous differentiation and activation of certain T helper (Th) subpopulations and macrophages in various loci of the tumor, their phenotypic plasticity, and their antagonism of Th1 and Th2 responses. Evidence is provided to demonstrate that the IIR type in the tumor microenvironment determines the probability of the epithelial–mesenchymal transition (EMT), the emergence of invasive properties in tumor cells, the formation of tumor and premetastatic niches, and chemosensitivity. It is hypothesized that the effect of IIRs on tumor cells depends on the IIR type, which determines the cell and cytokine spectrum in the tumor microenvironment, rather than on the efficiency of specific immune responses to tumor antigens. Lastly, it is assumed that more efficient targets for IIR guidance are not provided by single molecules, but rather by the signaling pathways that can permanently prevent the Th2-type IIRs or suppress inflammatory reactions in the tumor.

Об авторах

V. Perelmuter

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: d_evgeniy@oncology.tomsk.ru
Россия, Tomsk, 634050

L. Tashireva

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: d_evgeniy@oncology.tomsk.ru
Россия, Tomsk, 634050

V. Manskikh

Department of Bioengineering and Bioinformatics, Moscow State University

Email: d_evgeniy@oncology.tomsk.ru
Россия, Moscow, 119991

E. Denisov

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State University

Автор, ответственный за переписку.
Email: d_evgeniy@oncology.tomsk.ru
Россия, Tomsk, 634050; Tomsk, 634050

O. Savelieva

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State University

Email: d_evgeniy@oncology.tomsk.ru
Россия, Tomsk, 634050; Tomsk, 634050

E. Kaygorodova

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences

Email: d_evgeniy@oncology.tomsk.ru
Россия, Tomsk, 634050

M. Zavyalova

Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State University; Siberian State Medical University

Email: d_evgeniy@oncology.tomsk.ru
Россия, Tomsk, 634050; Tomsk, 634050; Tomsk, 634050


© Pleiades Publishing, Ltd., 2018

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах